{"transactions":[{"id":1394105,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2024-10-02T14:16:27.000Z","date":"2024-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":9645,"price":4.88,"value":47067.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 ."}],"balance_after":980726,"source":{"system":"sec-edgar","filing":"0001214659-24-017011","document":"marketforms-67099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465924017011/marketforms-67099.xml","form_type":"4/A","original_submission_date":"2024-03-12"}},{"id":1568280,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2024-03-19T14:30:50.000Z","date":"2024-03-15","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":6,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 6, 2023."}],"balance_after":984476,"source":{"system":"sec-edgar","filing":"0001214659-24-004795","document":"marketforms-65280.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465924004795/marketforms-65280.xml","form_type":"4"}},{"id":1580865,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2024-03-12T13:45:40.000Z","date":"2024-03-09","kind":"tax_withholding","planned":true,"acquired":false,"shares":5895,"price":4.88,"value":28767.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":1034476,"source":{"system":"sec-edgar","filing":"0001214659-24-004389","document":"marketforms-65141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465924004389/marketforms-65141.xml","form_type":"4"}},{"id":1580864,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2024-03-12T13:45:40.000Z","date":"2024-03-08","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":5.1874,"value":129685.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $5.00 to $5.60 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1040371,"source":{"system":"sec-edgar","filing":"0001214659-24-004389","document":"marketforms-65141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465924004389/marketforms-65141.xml","form_type":"4"}},{"id":1583945,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-03-11T10:36:03.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":41250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":41250,"derivative":{"exercise_price":5.68,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":41250},"source":{"system":"sec-edgar","filing":"0001214659-24-004307","document":"marketforms-64693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465924004307/marketforms-64693.xml","form_type":"4"}},{"id":1583944,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2024-03-11T10:36:03.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":1065371,"source":{"system":"sec-edgar","filing":"0001214659-24-004307","document":"marketforms-64693.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465924004307/marketforms-64693.xml","form_type":"4"}},{"id":1811890,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Performance Stock Units","published_at":"2023-08-09T16:30:22.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based stock unit (\"PSU\") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance-based stock unit (\"PSU\") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period."}],"balance_after":50000,"derivative":{"expiration_date":"2026-05-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-23-010922","document":"marketforms-61881.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465923010922/marketforms-61881.xml","form_type":"4"}},{"id":1902439,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Performance Stock Units","published_at":"2023-05-05T16:00:43.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of Aquestive (\"Company\") common stock. The PSUs have a three-year Performance Period, and, to the extent\nearned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the\nlast day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results\nof the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior\nto and including the last calendar day of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of Aquestive (\"Company\") common stock. The PSUs have a three-year Performance Period, and, to the extent\nearned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the\nlast day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results\nof the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior\nto and including the last calendar day of the Performance Period."}],"balance_after":50000,"derivative":{"expiration_date":"2026-05-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-23-006558","document":"marketforms-61240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465923006558/marketforms-61240.xml","form_type":"4"}},{"id":1960858,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2023-03-09T15:07:20.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":982871,"source":{"system":"sec-edgar","filing":"0001214659-23-003692","document":"marketforms-59529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465923003692/marketforms-59529.xml","form_type":"4"}},{"id":2122148,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-11-08T10:22:38.000Z","date":"2022-11-04","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":40000,"derivative":{"exercise_price":0.875,"expiration_date":"2032-11-04","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001214659-22-013279","document":"marketforms-57373.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465922013279/marketforms-57373.xml","form_type":"4"}},{"id":2235741,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2022-06-10T17:26:41.000Z","date":"2022-06-08","kind":"purchase","acquired":true,"shares":45871,"price":0.13,"value":5963.23,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13."}],"balance_after":45871,"derivative":{"exercise_price":0.96,"exercise_date":"2022-12-08","expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":45871},"source":{"system":"sec-edgar","filing":"0001628280-22-016875","document":"wf-form4_165489638239475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000162828022016875/wf-form4_165489638239475.xml","form_type":"4"}},{"id":2235740,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2022-06-10T17:26:41.000Z","date":"2022-06-08","kind":"purchase","acquired":true,"shares":45871,"price":0.96,"value":44036.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13."}],"balance_after":882871,"source":{"system":"sec-edgar","filing":"0001628280-22-016875","document":"wf-form4_165489638239475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000162828022016875/wf-form4_165489638239475.xml","form_type":"4"}},{"id":2335282,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-14T11:25:56.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":75000,"derivative":{"exercise_price":2.55,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001214659-22-003898","document":"marketforms-55764.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465922003898/marketforms-55764.xml","form_type":"4"}},{"id":2789062,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-15T17:10:26.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":70000,"derivative":{"exercise_price":5.3,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001214659-21-003148","document":"marketforms-51881.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465921003148/marketforms-51881.xml","form_type":"4"}},{"id":2868942,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2021-02-10T20:17:36.000Z","date":"2021-02-10","kind":"sale","acquired":false,"shares":23460,"price":6.75,"value":158355.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2020."}],"balance_after":837000,"source":{"system":"sec-edgar","filing":"0001214659-21-001520","document":"marketforms-51450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465921001520/marketforms-51450.xml","form_type":"4"}},{"id":2868941,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2021-02-10T20:17:36.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":11540,"price":6.75,"value":77895.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2020."}],"balance_after":860460,"source":{"system":"sec-edgar","filing":"0001214659-21-001520","document":"marketforms-51450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465921001520/marketforms-51450.xml","form_type":"4"}},{"id":2871611,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2021-02-09T16:00:20.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":40792,"price":6.5,"value":265148.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2020."}],"balance_after":872000,"source":{"system":"sec-edgar","filing":"0001214659-21-001480","document":"marketforms-51446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465921001480/marketforms-51446.xml","form_type":"4"}},{"id":3091470,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2020-07-02T16:00:31.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2020-06-30","underlying":"Common Stock","underlying_shares":333},"source":{"system":"sec-edgar","filing":"0001214659-20-006105","document":"marketforms-49165.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920006105/marketforms-49165.xml","form_type":"4"}},{"id":3091469,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-07-02T16:00:31.000Z","date":"2020-06-30","kind":"tax_withholding","acquired":false,"shares":94,"price":4.86,"value":456.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":912792,"source":{"system":"sec-edgar","filing":"0001214659-20-006105","document":"marketforms-49165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920006105/marketforms-49165.xml","form_type":"4"}},{"id":3091468,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-07-02T16:00:31.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":912886,"source":{"system":"sec-edgar","filing":"0001214659-20-006105","document":"marketforms-49165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920006105/marketforms-49165.xml","form_type":"4"}},{"id":3126758,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2020-06-02T17:14:15.000Z","date":"2020-05-31","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2020-05-31","underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001214659-20-005339","document":"marketforms-48951.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920005339/marketforms-48951.xml","form_type":"4"}},{"id":3126757,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-06-02T17:14:15.000Z","date":"2020-05-31","kind":"tax_withholding","acquired":false,"shares":4132,"price":4.87,"value":20122.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":912553,"source":{"system":"sec-edgar","filing":"0001214659-20-005339","document":"marketforms-48951.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920005339/marketforms-48951.xml","form_type":"4"}},{"id":3126756,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-06-02T17:14:15.000Z","date":"2020-05-31","kind":"exercise","acquired":true,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":916685,"source":{"system":"sec-edgar","filing":"0001214659-20-005339","document":"marketforms-48951.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920005339/marketforms-48951.xml","form_type":"4"}},{"id":3154252,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-05-11T16:15:14.000Z","date":"2020-05-08","kind":"sale","acquired":false,"shares":40000,"price":5,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on March 16, 2020."}],"balance_after":902113,"source":{"system":"sec-edgar","filing":"0001214659-20-004314","document":"marketforms-48764.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920004314/marketforms-48764.xml","form_type":"4"}},{"id":3163521,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-05-04T16:05:26.000Z","date":"2020-04-27","kind":"sale","acquired":false,"shares":40000,"price":4,"value":160000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a Rule 10b5-1 Stock Trading Plan."}],"balance_after":942113,"source":{"system":"sec-edgar","filing":"0001214659-20-004018","document":"marketforms-48670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920004018/marketforms-48670.xml","form_type":"4"}},{"id":3163520,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-05-04T16:05:26.000Z","date":"2020-04-14","kind":"sale","acquired":false,"shares":40000,"price":3.7,"value":148000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a Rule 10b5-1 Stock Trading Plan."}],"balance_after":982113,"source":{"system":"sec-edgar","filing":"0001214659-20-004018","document":"marketforms-48670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920004018/marketforms-48670.xml","form_type":"4"}},{"id":3165284,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-05-01T16:05:18.000Z","date":"2020-04-29","kind":"sale","acquired":false,"shares":40000,"price":4.5,"value":180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a Rule 10b5-1 Stock Trading Plan."}],"balance_after":1022113,"source":{"system":"sec-edgar","filing":"0001214659-20-003962","document":"marketforms-48653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920003962/marketforms-48653.xml","form_type":"4"}},{"id":3186314,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2020-04-02T16:16:01.000Z","date":"2020-03-31","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":333,"derivative":{"exercise_price":0,"exercise_date":"2020-03-31","underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001214659-20-003145","document":"marketforms-48495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920003145/marketforms-48495.xml","form_type":"4"}},{"id":3186313,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-04-02T16:16:01.000Z","date":"2020-03-31","kind":"tax_withholding","acquired":false,"shares":97,"price":2.19,"value":212.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":1062113,"source":{"system":"sec-edgar","filing":"0001214659-20-003145","document":"marketforms-48495.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920003145/marketforms-48495.xml","form_type":"4"}},{"id":3186312,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-04-02T16:16:01.000Z","date":"2020-03-31","kind":"exercise","acquired":true,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1062210,"source":{"system":"sec-edgar","filing":"0001214659-20-003145","document":"marketforms-48495.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920003145/marketforms-48495.xml","form_type":"4"}},{"id":3202295,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-03-18T16:47:47.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries."}],"balance_after":70000,"derivative":{"exercise_price":1.54,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001214659-20-002752","document":"marketforms-48343.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920002752/marketforms-48343.xml","form_type":"4"}},{"id":3231830,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T19:38:16.000Z","date":"2020-02-29","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":14572,"derivative":{"exercise_price":0,"exercise_date":"2020-02-29","underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001214659-20-002184","document":"marketforms-48058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920002184/marketforms-48058.xml","form_type":"4"}},{"id":3231829,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-03-03T19:38:16.000Z","date":"2020-02-29","kind":"tax_withholding","acquired":false,"shares":5066,"price":3.73,"value":18896.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":1061881,"source":{"system":"sec-edgar","filing":"0001214659-20-002184","document":"marketforms-48058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920002184/marketforms-48058.xml","form_type":"4"}},{"id":3231828,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-03-03T19:38:16.000Z","date":"2020-02-29","kind":"exercise","acquired":true,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1066947,"source":{"system":"sec-edgar","filing":"0001214659-20-002184","document":"marketforms-48058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920002184/marketforms-48058.xml","form_type":"4"}},{"id":3246124,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-02-26T16:20:14.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":147,"price":5.82,"value":855.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed solely to amend the number of withheld shares due to a mistake in the number of shares withheld upon vesting of RSUs as reported in the original Form 4 filed on January 2, 2020."}],"balance_after":1052375,"source":{"system":"sec-edgar","filing":"0001214659-20-001881","document":"marketforms-47924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920001881/marketforms-47924.xml","form_type":"4/A","original_submission_date":"2020-01-02"}},{"id":3246123,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-02-26T16:05:21.000Z","date":"2019-11-30","kind":"tax_withholding","acquired":false,"shares":6544,"price":7.79,"value":50977.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed solely to amend the number of withheld shares due to a mistake in the number of shares withheld upon vesting of RSUs as reported in the original Form 4 filed on December 2, 2019."}],"balance_after":1052193,"source":{"system":"sec-edgar","filing":"0001214659-20-001859","document":"marketforms-47923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920001859/marketforms-47923.xml","form_type":"4/A","original_submission_date":"2019-12-02"}},{"id":3326998,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2020-01-02T16:15:19.000Z","date":"2019-12-31","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":662,"derivative":{"exercise_price":0,"exercise_date":"2019-12-31","underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001214659-20-000041","document":"marketforms-47054.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920000041/marketforms-47054.xml","form_type":"4"}},{"id":3326997,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-01-02T16:15:19.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":329,"price":5.82,"value":1914.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":1044165,"source":{"system":"sec-edgar","filing":"0001214659-20-000041","document":"marketforms-47054.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920000041/marketforms-47054.xml","form_type":"4"}},{"id":3326996,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2020-01-02T16:15:19.000Z","date":"2019-12-31","kind":"exercise","acquired":true,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1044494,"source":{"system":"sec-edgar","filing":"0001214659-20-000041","document":"marketforms-47054.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465920000041/marketforms-47054.xml","form_type":"4"}},{"id":3355774,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2019-12-02T16:56:03.000Z","date":"2019-11-30","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":29144,"derivative":{"exercise_price":0,"exercise_date":"2019-11-30","underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001214659-19-007535","document":"marketforms-46718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919007535/marketforms-46718.xml","form_type":"4"}},{"id":3355773,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-12-02T16:56:03.000Z","date":"2019-11-30","kind":"tax_withholding","acquired":false,"shares":14572,"price":7.79,"value":113515.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":1044165,"source":{"system":"sec-edgar","filing":"0001214659-19-007535","document":"marketforms-46718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919007535/marketforms-46718.xml","form_type":"4"}},{"id":3355772,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-12-02T16:56:03.000Z","date":"2019-11-30","kind":"exercise","acquired":true,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1058737,"source":{"system":"sec-edgar","filing":"0001214659-19-007535","document":"marketforms-46718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919007535/marketforms-46718.xml","form_type":"4"}},{"id":3400856,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2019-10-02T16:33:51.000Z","date":"2019-09-30","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":991,"derivative":{"exercise_price":0,"exercise_date":"2019-09-30","underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001214659-19-006188","document":"marketforms-45866.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919006188/marketforms-45866.xml","form_type":"4"}},{"id":3400855,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-10-02T16:33:51.000Z","date":"2019-09-30","kind":"tax_withholding","acquired":false,"shares":145,"price":3.18,"value":461.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":1044165,"source":{"system":"sec-edgar","filing":"0001214659-19-006188","document":"marketforms-45866.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919006188/marketforms-45866.xml","form_type":"4"}},{"id":3400854,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-10-02T16:33:51.000Z","date":"2019-09-30","kind":"exercise","acquired":true,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1044310,"source":{"system":"sec-edgar","filing":"0001214659-19-006188","document":"marketforms-45866.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919006188/marketforms-45866.xml","form_type":"4"}},{"id":3424831,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2019-09-03T18:09:06.000Z","date":"2019-08-31","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":43716,"derivative":{"exercise_price":0,"exercise_date":"2019-08-31","underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001214659-19-005618","document":"marketforms-45658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919005618/marketforms-45658.xml","form_type":"4"}},{"id":3424830,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-09-03T18:09:06.000Z","date":"2019-08-31","kind":"tax_withholding","acquired":false,"shares":6460,"price":3.8,"value":24548.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":1043981,"source":{"system":"sec-edgar","filing":"0001214659-19-005618","document":"marketforms-45658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919005618/marketforms-45658.xml","form_type":"4"}},{"id":3424829,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-09-03T18:09:06.000Z","date":"2019-08-31","kind":"exercise","acquired":true,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1050441,"source":{"system":"sec-edgar","filing":"0001214659-19-005618","document":"marketforms-45658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919005618/marketforms-45658.xml","form_type":"4"}},{"id":3470958,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2019-07-02T16:30:12.000Z","date":"2019-06-30","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":1320,"derivative":{"exercise_price":0,"exercise_date":"2019-06-30","underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001214659-19-004458","document":"marketforms-45276.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919004458/marketforms-45276.xml","form_type":"4"}},{"id":3470957,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-07-02T16:30:12.000Z","date":"2019-06-30","kind":"tax_withholding","acquired":false,"shares":149,"price":4.2,"value":625.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":1035869,"source":{"system":"sec-edgar","filing":"0001214659-19-004458","document":"marketforms-45276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919004458/marketforms-45276.xml","form_type":"4"}},{"id":3470956,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-07-02T16:30:12.000Z","date":"2019-06-30","kind":"exercise","acquired":true,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1036018,"source":{"system":"sec-edgar","filing":"0001214659-19-004458","document":"marketforms-45276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919004458/marketforms-45276.xml","form_type":"4"}},{"id":3504481,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2019-06-03T16:15:16.000Z","date":"2019-05-31","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":58288,"derivative":{"exercise_price":0,"exercise_date":"2019-05-31","underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001214659-19-003980","document":"marketforms-45121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919003980/marketforms-45121.xml","form_type":"4"}},{"id":3504480,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-06-03T16:15:16.000Z","date":"2019-05-31","kind":"tax_withholding","acquired":false,"shares":6591,"price":3.72,"value":24518.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":1035689,"source":{"system":"sec-edgar","filing":"0001214659-19-003980","document":"marketforms-45121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919003980/marketforms-45121.xml","form_type":"4"}},{"id":3504479,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-06-03T16:15:16.000Z","date":"2019-05-31","kind":"exercise","acquired":true,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1042280,"source":{"system":"sec-edgar","filing":"0001214659-19-003980","document":"marketforms-45121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919003980/marketforms-45121.xml","form_type":"4"}},{"id":3571848,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2019-04-01T16:40:57.000Z","date":"2019-03-31","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":1649,"derivative":{"exercise_price":0,"exercise_date":"2019-03-31","underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001214659-19-002419","document":"marketforms-44721.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919002419/marketforms-44721.xml","form_type":"4"}},{"id":3571847,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-04-01T16:40:57.000Z","date":"2019-03-31","kind":"tax_withholding","acquired":false,"shares":263,"price":6.91,"value":1817.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":1027708,"source":{"system":"sec-edgar","filing":"0001214659-19-002419","document":"marketforms-44721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919002419/marketforms-44721.xml","form_type":"4"}},{"id":3571846,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-04-01T16:40:57.000Z","date":"2019-03-31","kind":"exercise","acquired":true,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1027971,"source":{"system":"sec-edgar","filing":"0001214659-19-002419","document":"marketforms-44721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919002419/marketforms-44721.xml","form_type":"4"}},{"id":3618685,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Chief Innov/Tech Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-03-04T16:50:50.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries."}],"balance_after":75000,"derivative":{"exercise_price":8.05,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001214659-19-001754","document":"marketforms-44356.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919001754/marketforms-44356.xml","form_type":"4"}},{"id":3623019,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-01T17:23:55.000Z","date":"2019-02-28","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"There are no expiration dates on RSUs."}],"balance_after":72860,"derivative":{"exercise_price":0,"exercise_date":"2019-02-28","underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001214659-19-001723","document":"marketforms-44305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919001723/marketforms-44305.xml","form_type":"4"}},{"id":3623018,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-03-01T17:23:55.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":6721,"price":8.05,"value":54104.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability."}],"balance_after":1027642,"source":{"system":"sec-edgar","filing":"0001214659-19-001723","document":"marketforms-44305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919001723/marketforms-44305.xml","form_type":"4"}},{"id":3623017,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-03-01T17:23:55.000Z","date":"2019-02-28","kind":"exercise","acquired":true,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1034363,"source":{"system":"sec-edgar","filing":"0001214659-19-001723","document":"marketforms-44305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000121465919001723/marketforms-44305.xml","form_type":"4"}},{"id":3708294,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-01-03T17:30:00.000Z","date":"2018-12-31","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on September 30, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on September 30, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."}],"balance_after":1978,"derivative":{"underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001140361-19-000283","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036119000283/form4.xml","form_type":"4"}},{"id":3708293,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-01-03T17:30:00.000Z","date":"2018-12-31","kind":"tax_withholding","acquired":false,"shares":162,"price":6.3,"value":1020.6,"ownership":{"direct":true},"balance_after":1019791,"source":{"system":"sec-edgar","filing":"0001140361-19-000283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036119000283/form4.xml","form_type":"4"}},{"id":3708292,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2019-01-03T17:30:00.000Z","date":"2018-12-31","kind":"exercise","acquired":true,"shares":329,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1019953,"source":{"system":"sec-edgar","filing":"0001140361-19-000283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036119000283/form4.xml","form_type":"4"}},{"id":3735346,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2018-12-11T17:41:13.000Z","date":"2018-12-10","kind":"purchase","acquired":true,"shares":1000,"price":7.78,"value":7780.0,"ownership":{"direct":true},"balance_after":1019624,"source":{"system":"sec-edgar","filing":"0001140361-18-044950","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118044950/form4.xml","form_type":"4"}},{"id":3737498,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2018-12-10T17:47:07.000Z","date":"2018-12-06","kind":"purchase","acquired":true,"shares":2000,"price":8.69,"value":17380.0,"ownership":{"direct":true},"balance_after":1018624,"source":{"system":"sec-edgar","filing":"0001140361-18-044870","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118044870/form4.xml","form_type":"4"}},{"id":3743480,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-12-04T16:05:07.000Z","date":"2018-11-30","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on August 31, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on August 31, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."}],"balance_after":87432,"derivative":{"underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001140361-18-044536","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118044536/form4.xml","form_type":"4"}},{"id":3743479,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2018-12-04T16:05:07.000Z","date":"2018-11-30","kind":"tax_withholding","acquired":false,"shares":7177,"price":8.59,"value":61650.43,"ownership":{"direct":true},"balance_after":1016624,"source":{"system":"sec-edgar","filing":"0001140361-18-044536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118044536/form4.xml","form_type":"4"}},{"id":3743478,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2018-12-04T16:05:07.000Z","date":"2018-11-30","kind":"exercise","acquired":true,"shares":14572,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1023801,"source":{"system":"sec-edgar","filing":"0001140361-18-044536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118044536/form4.xml","form_type":"4"}},{"id":3752822,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2018-11-26T13:43:06.000Z","date":"2018-11-21","kind":"purchase","acquired":true,"shares":1000,"price":10.25,"value":10250.0,"ownership":{"direct":true},"balance_after":1009229,"source":{"system":"sec-edgar","filing":"0001140361-18-043656","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118043656/form4.xml","form_type":"4"}},{"id":3801050,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-10-02T16:37:04.000Z","date":"2018-09-30","kind":"exercise","acquired":false,"shares":329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on September 30, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on September 30, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."}],"balance_after":2307,"derivative":{"underlying":"Common Stock","underlying_shares":329},"source":{"system":"sec-edgar","filing":"0001140361-18-039942","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118039942/form4.xml","form_type":"4"}},{"id":3801049,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2018-10-02T16:37:04.000Z","date":"2018-09-30","kind":"tax_withholding","acquired":false,"shares":162,"price":17.51,"value":2836.62,"ownership":{"direct":true},"balance_after":1008229,"source":{"system":"sec-edgar","filing":"0001140361-18-039942","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118039942/form4.xml","form_type":"4"}},{"id":3801048,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2018-10-02T16:37:04.000Z","date":"2018-09-30","kind":"exercise","acquired":true,"shares":329,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1008391,"source":{"system":"sec-edgar","filing":"0001140361-18-039942","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118039942/form4.xml","form_type":"4"}},{"id":3825242,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-09-05T17:39:56.000Z","date":"2018-08-31","kind":"exercise","acquired":false,"shares":14572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on August 31, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on August 31, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."}],"balance_after":102004,"derivative":{"underlying":"Common Stock","underlying_shares":14572},"source":{"system":"sec-edgar","filing":"0001140361-18-037868","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118037868/form4.xml","form_type":"4"}},{"id":3825241,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2018-09-05T17:39:56.000Z","date":"2018-08-31","kind":"tax_withholding","acquired":false,"shares":6510,"price":18.01,"value":117245.1,"ownership":{"direct":true},"balance_after":1008062,"source":{"system":"sec-edgar","filing":"0001140361-18-037868","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118037868/form4.xml","form_type":"4"}},{"id":3825240,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Common Stock","published_at":"2018-09-05T17:39:56.000Z","date":"2018-08-31","kind":"exercise","acquired":true,"shares":14572,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1014572,"source":{"system":"sec-edgar","filing":"0001140361-18-037868","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118037868/form4.xml","form_type":"4"}},{"id":3840071,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-08-17T18:47:33.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":2636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on September 30, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on September 30, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."}],"balance_after":2636,"derivative":{"underlying":"Common Stock","underlying_shares":2636},"source":{"system":"sec-edgar","filing":"0001140361-18-036639","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118036639/form4.xml","form_type":"4"}},{"id":3840070,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-08-17T18:47:33.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":28043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments beginning on September 30, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":28043,"derivative":{"exercise_price":16.46,"expiration_date":"2028-08-15","underlying":"Common Stock","underlying_shares":28043},"source":{"system":"sec-edgar","filing":"0001140361-18-036639","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118036639/form4.xml","form_type":"4"}},{"id":3860771,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":true,"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-07-26T21:06:06.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":116576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on August 31, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on August 31, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof."}],"balance_after":116576,"derivative":{"underlying":"Common Stock","underlying_shares":116576},"source":{"system":"sec-edgar","filing":"0001140361-18-033737","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118033737/form4.xml","form_type":"4"}},{"id":3860770,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":87111,"kind":"person","name":"Schobel Alexander Mark","position":1,"cik":"0001406836","reported_name":"Schobel Alexander Mark","relationship":{"director":true,"officer":true,"officer_title":"Chief Innovation/Tech Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-07-26T21:06:06.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":240165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments beginning on August 31, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":240165,"derivative":{"exercise_price":15,"expiration_date":"2028-07-24","underlying":"Common Stock","underlying_shares":240165},"source":{"system":"sec-edgar","filing":"0001140361-18-033737","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406836/000114036118033737/form4.xml","form_type":"4"}}]}